Biotechne revenue
WebAug 4, 2024 · Revenue. Net sales for the fourth quarter increased 11% to $288.2 million. Organic growth was 14% compared to the prior year with foreign currency exchange … WebApr 11, 2024 · According to my valuation model, Bio-Techne seems to be fairly priced at around 15.97% above my intrinsic value, which means if you buy Bio-Techne today, you’d be paying a relatively fair price ...
Biotechne revenue
Did you know?
WebApr 14, 2024 · Bio-Techne had a return on equity of 15.87% and a net margin of 23.38%. The business had revenue of $271.58 million during the quarter, compared to analysts’ … WebBiotechne Complex's headquarters are located at 670-b E Kytle St, Cleveland, Georgia, 30528, United States What is Biotechne Complex's phone number? Biotechne Complex's phone number is (706) 219-3836 What is Biotechne Complex's official website?
WebApr 14, 2024 · The company had revenue of $271.58 million for the quarter, compared to analysts’ expectations of $289.98 million. Bio-Techne had a return on equity of 15.87% … WebBio-Techne's Mission is to build Epic Tools for Epic Science. We have a creative, caring team of colleagues throughout the world who bring unique perspectives and talents in support of that Mission and who embody our …
Web2 days ago · The firm has a market cap of $12.24 billion, a PE ratio of 48.32, a price-to-earnings-growth ratio of 2.40 and a beta of 1.25. Bio-Techne Co. has a 52-week low of $68.00 and a 52-week high of $108.19. The company has a quick ratio of 3.15, a current ratio of 4.40 and a debt-to-equity ratio of 0.11. Web1 day ago · The company's revenue increased 3% in the first six months of fiscal 2024 over the same period of 2024. Income was down about 1% to $139.7 million for that period.
WebApr 11, 2024 · The business had revenue of $271.58 million during the quarter, compared to analysts’ expectations of $289.98 million. Bio-Techne had a return on equity of 15.87% and a net margin of 23.38%.
WebApr 14, 2024 · The firm had revenue of $271.58 million during the quarter, compared to the consensus estimate of $289.98 million. As a group, equities analysts forecast that Bio-Techne Co. will post 1.75 ... high school dxd hero 11 vostfrWebFeb 1, 2024 · Second quarter year-over-year organic growth for the segment was 7 percent, with acquisitions contributing 16 percent to revenue growth. Bio-Techne posted Q2 … high school dxd hero 12 vostfrWebAug 5, 2024 · Revenue. Net sales for the full year fiscal 2024 increased 26% to $931.0 million. Organic growth was 22%, with foreign currency translation and acquisitions having a favorable impact of 3% and 1% ... high school dxd hero 10 cdaWebBio-Techne Corp net income for the twelve months ending December 31, 2024 was $0.262B, a 24.36% increase year-over-year. Bio-Techne Corp annual net income for … how many championship did larry bird winWebJun 25, 2024 · Bio-Techne's management team will hold a conference call tomorrow, June 26, 2024 at 8:00 am CDT to discuss the Exosome Diagnostics acquisition. Interested parties may listen to the conference call by dialing 800-263-0877 or 646-828-8143 (for international callers) and referencing conference ID: 7186638. high school dxd hellWebFeb 2, 2024 · Analysts expected revenue of $206.5 million, for the quarter. Bio-Techne Corporation said its Board of Directors has decided to pay a dividend of $0.32 per share … how many championship did kobe winWebRevenue Top technologies; Illumina Inc. 10.2 K: $4.6 B: IdentityMine Base Space Illumina GenomeStudio Illumina BeadChip IdentityForge . Molecular Devices LLC. 1,100: $341.6 M: GenePix Microarray Scanner SoftMax Pro Mojo Networks Mojo AirTight . Promega Corp. 1,800: $478.8 M: Bio-Rad Laboratories Inc. 8,200: $2.8 B: Takara Bio Inc. high school dxd hero 5 temporada